Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML was started in November 1989. Today Shilpa Medicare Limited is a global brand in manufacturing and supplying of affordable API and Formulation globally in different regulated markets. Shilpa Pharma, Inc. is the US operating company of Shilpa Medicare Limited, one of the largest specialty generic pharmaceutical companies in the world. Based in India, they have API and finished formulation production facilities while providing high-quality, affordable medicines trusted by healthcare professionals and patients in over 100 countries globally. Shilpa Medicare Limited is establishing collaborations including in/out-licensing of products and technologies, strategic alliances, joint ventures, and mergers and acquisitions as they strengthen their presence in other markets across the world. Shilpa Pharma, Inc. will develop and support these collaborations here in the US.